戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lity-of-life questionnaire for patients with chemotherapy-induced peripheral neuropathy.
2 re no known effective treatments for painful chemotherapy-induced peripheral neuropathy.
3 tment protocols has the potential to prevent chemotherapy-induced peripheral neuropathy.
4 cularly bortezomib, have significant risk of chemotherapy-induced peripheral neuropathy.
5 ead of VPT measurements in future studies of chemotherapy-induced peripheral neuropathy.
6 independent predictors of the development of chemotherapy-induced peripheral neuropathy.
7 ment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20 tool.
8 fe Questionnaire (QLQ) C30 and the EORTC QLQ Chemotherapy-Induced Peripheral Neuropathy 20.
9 Research and Treatment of Cancer (EORTC) QLQ-chemotherapy-induced peripheral neuropathy-20 (CIPN20) i
10 urotoxicity of cisplatin in rodent models of chemotherapy-induced peripheral neuropathy and explored
11          Data on prevention and treatment of chemotherapy-induced peripheral neuropathy are limited.
12 no effective disease-modifying therapies for chemotherapy-induced peripheral neuropathies, but these
13 for Research and Treatment of Cancer (EORTC) Chemotherapy-Induced Peripheral Neuropathy (CIPN) -20 in
14                                              Chemotherapy-induced peripheral neuropathy (CIPN) accomp
15 e an understanding of the pathophysiology of chemotherapy-induced peripheral neuropathy (CIPN) and ma
16 enotype in a preclinical model of bortezomib chemotherapy-induced peripheral neuropathy (CIPN) and to
17                                              Chemotherapy-induced peripheral neuropathy (CIPN) arises
18                                              Chemotherapy-induced peripheral neuropathy (CIPN) is a c
19                                              Chemotherapy-induced peripheral neuropathy (CIPN) is a c
20                                              Chemotherapy-induced peripheral neuropathy (CIPN) is a c
21                                              Chemotherapy-induced peripheral neuropathy (CIPN) is a d
22                                              Chemotherapy-induced peripheral neuropathy (CIPN) is a d
23                                              Chemotherapy-induced peripheral neuropathy (CIPN) is a m
24                                              Chemotherapy-induced peripheral neuropathy (CIPN) is a s
25                                              Chemotherapy-induced peripheral neuropathy (CIPN) is com
26                                      Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may pe
27                                              Chemotherapy-induced peripheral neuropathy (CIPN) occurs
28                                              Chemotherapy-induced peripheral neuropathy (CIPN), chara
29 v1.7 are increased in a preclinical model of chemotherapy-induced peripheral neuropathy (CIPN), the m
30 be useful in the prevention and treatment of chemotherapy-induced peripheral neuropathy in humans.
31                                              Chemotherapy-induced peripheral neuropathy is a common,
32                                              Chemotherapy-induced peripheral neuropathy is a dose-lim
33                              The emphasis in chemotherapy-induced peripheral neuropathy is on trying
34 r, axon loss in most neuropathies, including chemotherapy-induced peripheral neuropathy, is the resul
35                                              Chemotherapy-induced peripheral neuropathy persists afte
36                  Among patients with painful chemotherapy-induced peripheral neuropathy, the use of d

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。